In the second study, those on the .25% had slightly more follicle growth than the .15% group. To get an even better picture of how the treatments work long term, Samumed is setting up another phase-two trial that will include both doses to figure out which one is the best to use in a phase-thee study that could set the treatment up for approval with the FDA.
That 3 month result gets me hard
I am a betting man, and if you were too, I would take that bet. Samumed is currently valued at $12bn after raising over $300m. If you were Samumed, you'd take your time bringing things to market, too, with that much at stake. They can't start shelving their pilot products and expect investor confidence to remain.If I was a betting man, the smart bet would be that this doesn't even get released
I just skimmed. Wish my Minoxidil results were that good.If I was a betting man, the smart bet would be that this doesn't even get released.
A 10% increase is not even as good as what conventional treatments can deliver and the fact that the lower dose gave the greater results means it's quite likely there's nothing you can do to squeeze any better results out of it then 10% and we don't even know that these results are permanent (probably not). Perhaps by some weird-*** voodoo, using it for extended periods of time would see continuous results, but I'm not holding my breath.
If they're doing another Phase 2, it's because they know the ship is sinking and this is the last-ditch effort to prove it can really make a difference. Otherwise, it's not worth bringing a treatment to market that can't compete with current products.
but hey, it's just more waste-of-time topicals for hairloss failing hard as usual.
That is a minoxidil patient
They can't start shelving their pilot products and expect investor confidence to remain.
10% is fantastic if it includes the hairline.
I would not scoff at that seeing as minoxidil and finasteride gave me exactly 0% regrowth
I would scoff at that because people who do respond to minoxidil and finasteride can expect to see those same results or better.
10% regrowth is only going to matter if it is a guaranteed, long-lasting or preferably permanent result. Otherwise, it's no competition for current treatments.
Also, Shiseido and Follica should be out within the next 3 years at the latest. We know the former stabilizes hairloss, seemingly indefinitely as predicted; the latter is rooted (ha) in wounding neogenesis (which we know grows hair), Puretech is making the move to the pivotal trial and they've been rallying dermatologists while keeping the public eye away from it, so it's a safe bet that whatever they have will offer superior results to conventional treatments and we can expect data on it soon, according to a recent article.
There's also the fact that a Japanese dude may very well perform successful hair cloning on humans in 2019 and if the cards are played right, rich bald dudes will be throwing money at it like a stripper the following year.
Despite their current value, I certainly wouldn't throw any money at samumed. At least, not based on their hairloss product.
But combined with OTHER treatments it might be a Godsend. I don't think we'll see a one-route cure for baldness in the next 20 years. But if we can tackle do the Wnt angle, the prostoglandin angle, the androgen angle, the bloodflow angle (or whatever the hell mino is supposed to do) etc etc... we might just stand a chance.
"If we combine then might be godsent " yeah if we combine with minoxidil alfatradiol finasteride andenosine ketoconizal ru dutasteride magic "italian lotion" dermaroller then some improvements might occur. Just lol. We need some thing effective as finasteride or minoxidil. Besides, everything need to be put in not effective category.
"We need some thing effective as finasteride or minoxidil.
This isn't true. Samumed is doing another phase II, which hasn't even started yet (https://clinicaltrials.gov/ct2/results?term=SM04554&Search=Search).
Per Business Insider in April: (http://www.businessinsider.com/samumed-wants-to-regenerate-hair-bone-cartilage-2017-3)
And I need a bigger dick.
I would scoff at that because people who do respond to minoxidil and finasteride can expect to see those same results or better.
10% regrowth is only going to matter if it is a guaranteed, long-lasting or preferably permanent result. Otherwise, it's no competition for current treatments.
Also, Shiseido and Follica should be out within the next 3 years at the latest.
